At Selexys, we are committed to advancing the understanding of inflammation and developing novel new products to treat inflammatory diseases. Our business is focused on helping patients who suffer these afflictions enjoy better and longer lives. Our pioneering work on the molecular mechanisms of inflammation has led to breakthroughs in novel therapeutics for inflammatory and thrombotic diseases and positioned Selexys with strong scientific underpinnings. Our Oklahoma based employees are committed to the highest standards of integrity and excellence in medical research. We invite you to explore our website and learn about our technology and the products that form our exciting new company!